Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STANDARD BIOTOOLS INC.LAB · Entity 6116 | Chief Financial Officer | February 21, 2023 | February 24, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STANDARD BIOTOOLS INC.
Report date February 21, 2023 · Filed February 24, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 217,622 |
Ending reported balance
After 2023-02-21 transaction · row 6
6 source rows · reconciled sequenceRow 1 · 2023-02-21 · Exercise / conversion · Acquired 50,000 · Balance 221,904 Row 2 · 2023-02-21 · Exercise / conversion · Acquired 16,666 · Balance 238,570 Row 3 · 2023-02-21 · Exercise / conversion · Acquired 2,238 · Balance 240,808 Row 4 · 2023-02-21 · Exercise / conversion · Acquired 2,391 · Balance 243,199 Row 5 · 2023-02-21 · Exercise / conversion · Acquired 3,130 · Balance 246,329 Row 6 · 2023-02-21 · Tax withholding · Disposed 28,707 · Balance 217,622 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-21 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2023-02-21 · Exercise / conversion · Disposed 50,000 · Balance 0 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F3: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause." |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 183,334 |
Reported balance
After 2023-02-21 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2023-02-21 · Exercise / conversion · Disposed 16,666 · Balance 183,334 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F4: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2023-02-21 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2023-02-21 · Exercise / conversion · Disposed 2,238 · Balance 0 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 9,563 |
Reported balance
After 2023-02-21 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2023-02-21 · Exercise / conversion · Disposed 2,391 · Balance 9,563 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F6: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 28,176 |
Reported balance
After 2023-02-21 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2023-02-21 · Grant · Disposed 3,130 · Balance 28,176 F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock. F7: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 52,061 |
Reported balance
Holding disclosure · report date 2023-02-21 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 52,061 F1: Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares held indirectly by the Vikram and Pratima Family Trust U/A dated June 23, 2009.
F2: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F3: The Restricted Stock Units vest in full on February 20, 2023 or the date the Reporting Person's employment with the Company is terminated involuntarily without "cause."
F4: On December 20, 2022, the Reporting Person was granted 200,000 Restricted Stock Units vesting in quarterly installments over the course of three years commencing February 20, 2023.
F5: On February 19, 2019, the Reporting Person was granted 35,787 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter.
F6: On March 10, 2020, the Reporting Person was granted 38,250 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter.
F7: On April 20, 2021, the Reporting Person was granted 50,089 Restricted Stock Units vesting as to 1/4 of the total number of shares on May 20, 2022, and as to 1/16th of the total number of shares each quarter thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2018 Filed Nov 22, 2018 02:07 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000117 · wf-form4_154285241953525.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:45 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 5,706 | $7.40 | $42,224.40 |
DisclosureSEC source: 0001162194-18-000109 · wf-form4_154163429892279.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,166 F3 · price: Equal to the closing price of one share of Issuer's common stock on November 5, 2018. Read SEC document |
| November 05, 2018 Filed Nov 7, 2018 23:45 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantCommon Stock | 16,503 | $6.29 | $103,803.87 |
DisclosureSEC source: 0001162194-18-000109 · wf-form4_154163429892279.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,872 F1 · security: Represents a grant of Restricted Stock Units issued pursuant to the Issuer's 2011 Equity Incentive Plan in connection with the Issuer's cash retention bonus exchange program. Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. 100% of the Restricted Stock Units vested on November 5, 2018. F1 · shares: Represents a grant of Restricted Stock Units issued pursuant to the Issuer's 2011 Equity Incentive Plan in connection with the Issuer's cash retention bonus exchange program. Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. 100% of the Restricted Stock Units vested on November 5, 2018. F2 · price: Equal to 85% of the closing price of one share of Issuer's common stock on November 5, 2018. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · derivative · entry 10 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,765 Underlying: Common Stock · 2,251 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F6 · derivative.exercise_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F6 · derivative.expiration_date: On June 11, 2018, the Reporting Person was granted 36,016 Restricted Stock Units of which 3/48th of the total number of shares underlying the Restricted Stock Units granted vested on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · derivative · entry 9 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,905 Underlying: Common Stock · 2,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F5 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F5 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,913 Underlying: Common Stock · 338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F4 · derivative.expiration_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 501 Underlying: Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F3 · derivative.expiration_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,748 | $6.74 | $11,781.52 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · nonDerivative · entry 5 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,369 Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,117 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 21:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000097 · wf-form4_153497167879027.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2018 Filed Jun 14, 2018 00:56 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantRestricted Stock Units · Derivative | 36,016 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000083 · wf-form4_152893778271091.xml · derivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,016 Underlying: Common Stock · 36,016 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F2 · derivative.exercise_date: 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to Reporting Person's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. F2 · derivative.expiration_date: 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest on August 20, 2018, and 3/48th of the total number of shares underlying the Restricted Stock Units granted will vest every three months thereafter until fully vested, subject to Reporting Person's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through the applicable vest date. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,067 Underlying: Common Stock · 2,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F5 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F5 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,251 Underlying: Common Stock · 337 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F4 · derivative.expiration_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 801 Underlying: Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 969 | $5.73 | $5,552.37 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,066 Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,872 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2018 Filed May 23, 2018 01:02 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000062 · wf-form4_152703727119964.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,535 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 19, 2018 Filed Mar 22, 2018 01:04 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 27,500 | $0.00 Strike: $6.33 | $0.00 |
DisclosureSEC source: 0001162194-18-000040 · wf-form4_152168063449590.xml · derivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,500 Underlying: Common Stock · 27,500 shares Expires 2028-03-19 F1 · derivative.exercise_date: 12/48th of the total number of shares subject to the Option will vest on March 19, 2019 and 1/48th of the total shares subject to the Option will vest and become exercisable each month thereafter over the succeeding 36 months, such that the Option will be fully vested on March 19, 2022, subject to the recipient's continued status as a Service Provider (as defined in the Company's 2011 Equity Incentive Plan) through each applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · derivative · entry 10 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,230 Underlying: Common Stock · 2,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F6 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · derivative · entry 9 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,588 Underlying: Common Stock · 338 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F5 · derivative.exercise_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F5 · derivative.expiration_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,101 Underlying: Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F4 · derivative.expiration_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On March 14, 2014, the Reporting Person was granted 5,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2014, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On March 14, 2014, the Reporting Person was granted 5,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2014, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,239 | $7.81 | $9,676.59 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · nonDerivative · entry 5 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,235 Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,474 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 338 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,974 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 21:32 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 234 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-18-000024 · wf-form4_151933512687064.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · derivative · entry 10 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,392 Underlying: Common Stock · 2,163 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F6 · derivative.exercise_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: On February 13, 2017, the Reporting Person was granted 34,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2017, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · derivative · entry 9 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,926 Underlying: Common Stock · 337 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F5 · derivative.exercise_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F5 · derivative.expiration_date: On March 4, 2016, the Reporting Person was granted 5,400 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2016, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,401 Underlying: Common Stock · 300 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F4 · derivative.exercise_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F4 · derivative.expiration_date: On March 12, 2015, the Reporting Person was granted 4,800 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2015, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionRestricted Stock Units · Derivative | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234 Underlying: Common Stock · 350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock upon vesting of the unit. F3 · derivative.exercise_date: On March 14, 2014, the Reporting Person was granted 5,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2014, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F3 · derivative.expiration_date: On March 14, 2014, the Reporting Person was granted 5,600 Restricted Stock Units of which 4/48th of the total number of shares underlying the Restricted Stock Units granted vested on May 20, 2014, and 3/48th of the total number of shares underlying the Restricted Stock Units granted have vested and will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Tax withholdingCommon Stock | 1,185 | $5.19 | $6,150.15 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · nonDerivative · entry 5 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,440 Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 2,163 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · nonDerivative · entry 4 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,625 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · nonDerivative · entry 3 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,462 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · nonDerivative · entry 2 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2017 Filed Nov 23, 2017 02:01 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Exercise / conversionCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0001162194-17-000169 · wf-form4_151140247571359.xml · nonDerivative · entry 1 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,825 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 8,941 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 12 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,941 Underlying: Common Stock · 8,941 shares Expires not disclosed F14 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,500 shares of FLDM common stock granted to the Reporting Person on March 4, 2016. In exchange, the Reporting Person received a replacement Option, for 8,941 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: The Option expiration date is September 20, 2027. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 13,500 | Not disclosed Strike: $7.10 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 11 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,500 shares Expires 2026-03-04 F14 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 13,500 shares of FLDM common stock granted to the Reporting Person on March 4, 2016. In exchange, the Reporting Person received a replacement Option, for 8,941 shares, having an exercise price of $5.13 per share. F13 · derivative.exercise_date: The Option provided for vesting in forty-eight equal monthly installments beginning February 1, 2016. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 2,073 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 10 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,073 Underlying: Common Stock · 2,073 shares Expires not disclosed F12 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 12,000 shares of FLDM common stock granted to the Reporting Person on March 12, 2015. In exchange, the Reporting Person received a replacement Option, for 2,073 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: The Option expiration date is September 20, 2027. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,000 | Not disclosed Strike: $41.14 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 9 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2025-03-12 F12 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 12,000 shares of FLDM common stock granted to the Reporting Person on March 12, 2015. In exchange, the Reporting Person received a replacement Option, for 2,073 shares, having an exercise price of $5.13 per share. F11 · derivative.exercise_date: The Option provided for vesting of 2/48th of the shares subject to the Option on March 12, 2015 and forty-six equal monthly installments beginning on April 1, 2015. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 1,541 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 8 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,541 Underlying: Common Stock · 1,541 shares Expires not disclosed F10 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 14,000 shares of FLDM common stock granted to the Reporting Person on March 14, 2014. In exchange, the Reporting Person received a replacement Option, for 1,541 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: The Option expiration date is September 20, 2027. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 14,000 | Not disclosed Strike: $47.55 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 7 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2024-03-14 F10 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 14,000 shares of FLDM common stock granted to the Reporting Person on March 14, 2014. In exchange, the Reporting Person received a replacement Option, for 1,541 shares, having an exercise price of $5.13 per share. F9 · derivative.exercise_date: The Option provided for vesting in forty-eight equal monthly installments beginning January 1, 2014. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,609 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 6 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,609 Underlying: Common Stock · 6,609 shares Expires not disclosed F8 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 24,452 shares of FLDM common stock granted to the Reporting Person on February 15, 2013. In exchange, the Reporting Person received a replacement Option, for 6,609 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: The Option expiration date is September 20, 2027. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 24,452 | Not disclosed Strike: $16.73 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 5 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,452 shares Expires 2023-02-15 F8 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 24,452 shares of FLDM common stock granted to the Reporting Person on February 15, 2013. In exchange, the Reporting Person received a replacement Option, for 6,609 shares, having an exercise price of $5.13 per share. F7 · derivative.exercise_date: The shares subject to the Option fully vested on January 1, 2017. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 3,444 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 4 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,444 Underlying: Common Stock · 3,444 shares Expires not disclosed F5 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 12,501 shares of FLDM common stock granted to the Reporting Person on February 17, 2012. In exchange, the Reporting Person received a replacement Option, for 3,444 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. F6 · derivative.expiration_date: The Option expiration date is September 20, 2027. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | Disposition to issuerEmployee Stock Option (Right to Buy) · Derivative | 12,501 | Not disclosed Strike: $15.49 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 3 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,501 shares Expires 2022-02-16 F5 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 12,501 shares of FLDM common stock granted to the Reporting Person on February 17, 2012. In exchange, the Reporting Person received a replacement Option, for 3,444 shares, having an exercise price of $5.13 per share. F4 · derivative.exercise_date: The shares subject to the Option fully vested on January 1, 2016. Read SEC document |
| September 20, 2017 Filed Sep 23, 2017 01:16 UTC | STANDARD BIOTOOLS INC. FLDM · Entity 6116 | GrantEmployee Stock Option (Right to Buy) · Derivative | 967 | Not disclosed Strike: $5.13 | Not disclosed |
DisclosureSEC source: 0001162194-17-000144 · wf-form4_150612937289117.xml · derivative · entry 2 JOG VIKRAM · CIK 0001222641 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 967 Underlying: Common Stock · 967 shares Expires 2027-09-20 F2 · price: On September 20, 2017, the Issuer cancelled, pursuant to the Issuer's option exchange program, an Option for 3,334 shares of FLDM common stock granted to the Reporting Person on May 18, 2011. In exchange, the Reporting Person received a replacement Option, for 967 shares, having an exercise price of $5.13 per share. F3 · derivative.exercise_date: 1/12th of the total number of shares underlying the Option will vest on February 20, 2018, and 1/12th of the total number of shares underlying the Option granted will vest every three months thereafter until fully vested, subject to recipient's continued status as a Service Provider as defined in the Company's 2011 Equity Incentive Plan through the applicable vest date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.